Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease

Gabriella Assante, Sriram Chandrasekaran, Stanley Ng, Aikaterini Tourna, Carolina H. Chung, Kowsar A. Isse, Celine Filippi, Anil Dhawan, Mo Liu, Steven G. Rozen, Matthew Hoare, Peter Campbell, J. William. O. Ballard, Nigel Turner, Margaret J. Morris, Shilpa Chokshi, Neil A Youngson
doi: https://doi.org/10.1101/2021.07.22.453333
Gabriella Assante
1Institute of Hepatology, Foundation for Liver Research, London, United Kingdom
2King’s College London, Faculty of Life Sciences and Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sriram Chandrasekaran
3Program in Chemical Biology, University of Michigan, Ann Arbor, MI, 48109, USA
4Center for Bioinformatics and Computational Medicine, Ann Arbor, MI, 48109, USA
5Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA
6Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, 48109, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanley Ng
7Wellcome Trust Sanger Institute, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aikaterini Tourna
1Institute of Hepatology, Foundation for Liver Research, London, United Kingdom
2King’s College London, Faculty of Life Sciences and Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolina H. Chung
5Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kowsar A. Isse
1Institute of Hepatology, Foundation for Liver Research, London, United Kingdom
2King’s College London, Faculty of Life Sciences and Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celine Filippi
8Institute of Liver Studies, King’s College Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anil Dhawan
8Institute of Liver Studies, King’s College Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mo Liu
9Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven G. Rozen
9Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Hoare
10CRUK Cambridge Institute, Cambridge, UK
11Department of Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Campbell
7Wellcome Trust Sanger Institute, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. William. O. Ballard
12Department of Ecology, Environment and Evolution, La Trobe University, Bundoora, Melbourne, Victoria 3086, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel Turner
13UNSW Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret J. Morris
13UNSW Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shilpa Chokshi
1Institute of Hepatology, Foundation for Liver Research, London, United Kingdom
2King’s College London, Faculty of Life Sciences and Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil A Youngson
1Institute of Hepatology, Foundation for Liver Research, London, United Kingdom
2King’s College London, Faculty of Life Sciences and Medicine, London, United Kingdom
13UNSW Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: n.youngson@researchinliver.org.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

The rate of nonalcoholic fatty liver disease (NAFLD)-associated hepatocellular carcinoma (HCC) is increasing worldwide, but the steps in precancerous hepatocytes which lead to HCC driver mutations are not well understood. Here we provide evidence that metabolically-driven histone hyperacetylation in steatotic hepatocytes can increase DNA damage to initiate carcinogenesis. Genome-wide histone acetylation is increased in steatotic livers of rodents fed high fructose or high fat diet. In vitro, steatosis relaxes chromatin and increases DNA damage marker γH2AX, which is reversed by inhibiting acetyl-CoA production. Steatosis-associated acetylation and γH2AX are enriched at gene clusters in telomere-proximal regions which contain HCC tumor suppressors in hepatocytes and human fatty livers. Regions of metabolically-driven epigenetic change also have increased levels of DNA mutation in non-cancerous tissue from NAFLD patients. Finally, genome-scale network modelling indicates that redox balance is a key contributor to this mechanism. Thus abnormal histone hyperacetylation is a potential initiating event in HCC carcinogenesis.

Competing Interest Statement

The authors have declared no competing interest.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 23, 2021.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease
Gabriella Assante, Sriram Chandrasekaran, Stanley Ng, Aikaterini Tourna, Carolina H. Chung, Kowsar A. Isse, Celine Filippi, Anil Dhawan, Mo Liu, Steven G. Rozen, Matthew Hoare, Peter Campbell, J. William. O. Ballard, Nigel Turner, Margaret J. Morris, Shilpa Chokshi, Neil A Youngson
bioRxiv 2021.07.22.453333; doi: https://doi.org/10.1101/2021.07.22.453333
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease
Gabriella Assante, Sriram Chandrasekaran, Stanley Ng, Aikaterini Tourna, Carolina H. Chung, Kowsar A. Isse, Celine Filippi, Anil Dhawan, Mo Liu, Steven G. Rozen, Matthew Hoare, Peter Campbell, J. William. O. Ballard, Nigel Turner, Margaret J. Morris, Shilpa Chokshi, Neil A Youngson
bioRxiv 2021.07.22.453333; doi: https://doi.org/10.1101/2021.07.22.453333

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cancer Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4850)
  • Biochemistry (10791)
  • Bioengineering (8040)
  • Bioinformatics (27282)
  • Biophysics (13971)
  • Cancer Biology (11119)
  • Cell Biology (16048)
  • Clinical Trials (138)
  • Developmental Biology (8777)
  • Ecology (13276)
  • Epidemiology (2067)
  • Evolutionary Biology (17353)
  • Genetics (11687)
  • Genomics (15915)
  • Immunology (11027)
  • Microbiology (26069)
  • Molecular Biology (10637)
  • Neuroscience (56526)
  • Paleontology (417)
  • Pathology (1732)
  • Pharmacology and Toxicology (3003)
  • Physiology (4543)
  • Plant Biology (9627)
  • Scientific Communication and Education (1614)
  • Synthetic Biology (2685)
  • Systems Biology (6975)
  • Zoology (1508)